BioPharma Credit PLC (OTCMKTS:BOPCF) Sees Large Increase in Short Interest

BioPharma Credit PLC (OTCMKTS:BOPCF) was the target of a significant growth in short interest in February. As of February 27th, there was short interest totaling 40,046 shares, a growth of 90,913.6% from the February 12th total of 44 shares. Based on an average daily trading volume, of 134,683 shares, the days-to-cover ratio is currently 0.3 days. Based on an average daily trading volume, of 134,683 shares, the days-to-cover ratio is currently 0.3 days.

BioPharma Credit Stock Performance

Shares of BioPharma Credit stock opened at $0.88 on Thursday. The company’s 50-day moving average price is $0.87 and its two-hundred day moving average price is $0.90. BioPharma Credit has a 52 week low of $0.78 and a 52 week high of $0.95.

About BioPharma Credit

BioPharma Credit (OTCMKTS: BOPCF) is a closed-end investment company that specializes in providing debt financing solutions to the global life sciences sector. The firm offers a range of credit products—including senior secured loans, convertible loans and royalty monetization structures—designed to meet the capital needs of biotechnology and pharmaceutical companies across pre-clinical, clinical and commercial stages. By focusing on secured and structured credit, BioPharma Credit seeks to deliver consistent income while managing risk through collateralized arrangements and diversified portfolios.

Since its inception in 2016, the company has built a track record of partnering with innovative drug developers and medical technology firms.